Spleen Targeted Premade EGFP mRNA Lipid Nanoparticle
Spleen Targeted Premade EGFP mRNA Lipid Nanoparticle is a LNP loaded with EGFP mRNA (m1Ψ) has spleen specific targeting effect after systemic administration.
The LNP is formulated with main ionizable lipid of SM102 and anionic lipid 18PA.
The payload EGFP mRNA (m1Ψ) has all the U bases 100% modified with N1-methyl-pseudouridine (m1Ψ). This LNP formulation showed enhanced delivery of spleen organ after in vivo delivery.
| Payload: | EGFP mRNA (m1Ψ) |
|---|---|
| Formulation: | Ionizable lipid, DSPC, PEG-2000 DMG, Cholesetrol |
| Storage Buffer: | 10% Sucrose in PBS |
| Appearance: | Clear and colorless |
| Storage: | -20° C or below. We recommend to minimize freeze-thaw cycles to preserve LNPs integrity. |
| Shipping: | Dry ice |
| Handling: | Avoid freeze and thaw |
| Concentration: | ~0.1 mg/mL |
| Stock: | On-demand |
Special formulation and other requirements are available up request. Contact us.
For Research Use Only. Not for use in diagnostic procedures.
Spleen Targeted EGFP mRNA Premade Lipid Nanoparticle
More Information

